Viewing Study NCT00022932


Ignite Creation Date: 2025-12-24 @ 9:46 PM
Ignite Modification Date: 2025-12-25 @ 7:26 PM
Study NCT ID: NCT00022932
Status: UNKNOWN
Last Update Posted: 2005-06-24
First Post: 2001-08-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP
Sponsor: Corixa Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module